Bristol-Myers Squibb Company obtained approvals of 18 new drugs and additional drug indications and formulations in 2022. These drugs are currently marketed in the company’s
Bristol-Myers Squibb Company obtained approvals of 18 new drugs and additional drug indications and formulations in 2022. These drugs are currently marketed in the company’s